106 related articles for article (PubMed ID: 3040031)
21. Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.
Toikkanen S; Eerola E; Ekfors TO
J Clin Pathol; 1988 Mar; 41(3):300-3. PubMed ID: 2834422
[TBL] [Abstract][Full Text] [Related]
22. Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease.
Eriksson E; Schimmelpenning H; Silfverswärd C; Auer G
Hum Pathol; 1992 Dec; 23(12):1366-72. PubMed ID: 1468773
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical detection of estrogen receptors in mammary Paget cells.
Tani EM; Skoog L
Acta Cytol; 1988; 32(6):825-8. PubMed ID: 2849272
[TBL] [Abstract][Full Text] [Related]
24. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
25. Image cytophotometric DNA histogram heterogeneity in adenocarcinoma of the breast.
Visscher DW; Shaheen C; Drozdowicz S; Crissman JD
Anal Quant Cytol Histol; 1993 Jun; 15(3):206-12. PubMed ID: 8347261
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptors in ductal carcinoma in situ of breast.
Malafa M; Chaudhuri B; Thomford NR; Chaudhuri PK
Am Surg; 1990 Jul; 56(7):436-9. PubMed ID: 2164337
[TBL] [Abstract][Full Text] [Related]
27. p53 mutations and expression in breast carcinoma in situ.
Lukas J; Niu N; Press MF
Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
[TBL] [Abstract][Full Text] [Related]
28. The content of tumor DNA as an indicator of prognosis in patients with T1N0M0 and T2N0M0 carcinoma of the breast.
Ellis CN; Frey ES; Burnette JJ; Akin JM; Reading C; Gaskin TA; Blakemore WS
Surgery; 1989 Aug; 106(2):133-8. PubMed ID: 2763022
[TBL] [Abstract][Full Text] [Related]
29. Nuclear DNA content and clinical follow-up in resected pancreatic adenocarcinoma.
Bui HX; Ballouk F; del Rosario A; Abdulla M; Khan M; Jennings TA; Ross JS
Anal Quant Cytol Histol; 1993 Dec; 15(6):389-95. PubMed ID: 8297429
[TBL] [Abstract][Full Text] [Related]
30. [Flow cytometric DNA measurements of thyroid carcinomas].
Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
[TBL] [Abstract][Full Text] [Related]
31. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
32. [Laser flow cytofluorometry as a supplementary method of determining the degree of tumor differentiation in breast cancer patients].
Bogatyrev VN; Ermilova VD; Petrova AS
Arkh Patol; 1986; 48(1):44-8. PubMed ID: 2421692
[TBL] [Abstract][Full Text] [Related]
33. [Cell nucleus analyses on the heterogenicity, proliferation and metastasis of malignant tumors].
Kunze KD; Haroske G; Dimmer V; Meyer W; Theissig F
Acta Histochem Suppl; 1990; 39():147-54. PubMed ID: 1964231
[TBL] [Abstract][Full Text] [Related]
34. DNA stainability in aneuploid breast tumors: comparison of four DNA fluorochromes differing in binding properties.
Myc A; Traganos F; Lara J; Melamed MR; Darzynkiewicz Z
Cytometry; 1992; 13(4):389-94. PubMed ID: 1326430
[TBL] [Abstract][Full Text] [Related]
35. A prospective comparison of DNA quantitation by image and flow cytometry.
Bauer TW; Tubbs RR; Edinger MG; Suit PF; Gephardt GN; Levin HS
Am J Clin Pathol; 1990 Mar; 93(3):322-6. PubMed ID: 2155525
[TBL] [Abstract][Full Text] [Related]
36. Cytochemical classification of nonpalpable breast carcinoma.
Fallenius A; Svane G; Auer G; Caspersson TO
Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
[TBL] [Abstract][Full Text] [Related]
37. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
[TBL] [Abstract][Full Text] [Related]
38. Expression of c-erb B-2 protein and DNA ploidy in breast carcinogenesis.
Schmitt FC; Figueiredo P; Lacerda M
Arch Pathol Lab Med; 1995 Sep; 119(9):815-20. PubMed ID: 7668939
[TBL] [Abstract][Full Text] [Related]
39. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma.
Erhardt K; Auer G; Folin A; Silfverswärd C; Skoog L
Am J Clin Oncol; 1986 Feb; 9(1):83-9. PubMed ID: 3006475
[TBL] [Abstract][Full Text] [Related]
40. [The changes in nuclear DNA amounts in the development and progression of uterine cervical cancer determined by cytofluorometry].
Harada K
Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):759-68. PubMed ID: 3722955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
